Background Postpartum haemorrhage (PPH) is the leading cause of maternal mortality
worldwide. Prophylactic uterotonic agents can prevent PPH, and are routinely …

The objective of our systematic review was to provide updated evidence-based guidance for
surgical decisions during cesarean delivery (CD). We performed an English-language …

Over the past few decades, there has been a tremendous increase in the utilization of
therapeutic peptides. Therapeutic peptides are usually administered via the parenteral …

Background Postpartum hemorrhage causes a quarter of global maternal deaths. The World
Health Organization recommends oxytocin as the first line agent to prevent hemorrhage …

BACKGROUND Postpartum haemorrhage (PPH) is the leading cause of maternal mortality
worldwide. Prophylactic uterotonic drugs can reduce blood loss and are routinely …

Objective To evaluate the efficacy and safety of prophylactic misoprostol use at cesarean
delivery for reducing intraoperative and postoperative hemorrhage. Study Design …

Background The primary objective of postpartum haemorrhage (PPH) prevention and
treatment is to reduce maternal deaths. Misoprostol has the major public health advantage …

Objectives To compare combined sublingual misoprostol plus oxytocin infusion with
intravenous carbetocin for prevention of postpartum hemorrhage (PPH) in patients with risk …

OBJECTIVE: To evaluate the effect of preoperative administration of rectal misoprostol on
blood loss during and after elective cesarean delivery. METHODS: A randomized controlled …

Purpose The commonest surgical procedure for women is cesarean delivery. Postpartum
hemorrhage and intra-operative blood during cesarean delivery is a major concern to all …